Atlas Trials

Safety and Immunogenicity of Different Meningitis Vaccine Formulations in Adolescents and Young Adults

Clinical trial NCT01272180 · COMPLETED

Trial details

NCT number
NCT01272180
Sponsor
Novartis Vaccines
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Invasive Meningococcal Disease
Start date
2011-08-01
Primary completion
2011-10-01
Enrollment
484

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.